参考文献/References:
[1] STERN ME,GAO J,SIEMASKO KF,BEUERMAN RW,PFLUGFELDER SC.The role of the lacrimal functional unit in the pathophysiology of dry eye[J].Exp Eye Res,2004,78(3):409-416.
[2] BREWITT H,SISTANI F.Dry eye disease:the scale of the problem[J].Surv Ophthalmol,2001,45(2):199-202.
[3] LV H,LI A,ZHANG X,XU M,QIAO Y.Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients[J].Acta Ophthalmol,2014,92(2):e96-104.
[4] BJERRUM KB.Test and symptoms in keratoconjunctivitis sicca and their correlation[J].Acta Ophthalmol Scand,1996,74:436-441.
[5] DOGRU M,KATAKAMI C,INOUE M.Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus[J].Ophthalmology,2001,108(3):586-592.
[6] OZDEMIR M,BUYUKBESE MA,CETINKAYA A,OZDEMIR G.Risk factors for ocular surface disorders in patients with diabetes mellitus[J].Diabetes Res Clin Pract,2003,59(3):195-199.
[7] YOON KC,IM SK,SEO MS.Changes of tear film and ocular surface in diabetes mellitus[J].Korean J Ophthalmol,2004,18(2):168-174.
[8] SAITO J,ENOKI M,HARA M,MORISHIGE N,CHIKAMA T,NISHIDA T.Correlation of corneal sensation,but not of basal or reflex tear secretion,with the stage of diabetic retinopathy[J].Cornea,2003,22(1):15-18.
[9] RAHMAN A,YAHYA K,AHMED T,SHARIF-UI-HASAN K.Diagnostic value of tear films tests in type 2 diabetes[J].J Pak Med Assoc,2007,57(12):577-581.
[10] 高妍,刘新玲,李筱荣.糖尿病患者眼表及泪液蛋白改变的临床分析[J].眼科新进展,2011,31(3):267-270.
GAO Y,LIU XL,LI XR.Clinical analysis of ocular surface and tear film changes in type 2 diatetes mellitus[J].Rec Adv Ophthalmol,2011,31(3):267-270.
[11] 赵萌,邹留河,焦璇,彭晓燕.糖尿病患者泪膜损伤的临床特征分析[J].中华实验眼科杂志,2011,29(11):1019-1022.
ZHAO M,ZOU LH,JIAO X,PENG XY.The clinical characters of tear film instability in diabetes patients[J].Chin J Exp Ophthalmol,2011,29(11):1019-1022.
[12] YU L,CHEN X,QIN G,XIE H,LV P.Tear film function in type 2 diabetic patients with retinopathy[J].Ophthalmologica,2008,222(4):284-291.
[13] LI B,SHENG M,XIE L,LIU F,YAN G,WANG W,et al.Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry[J].Invest Ophthalmol Vis Sci,2014,55(1):177-186.
[14] 金姬,陈丽红,刘秀伦.糖尿病患者泪膜功能的研究[J].中华眼科杂志,2003,39(1):10-13.
JIN J,CHEN LH,LIU XL.Tear film function in non-insulin dependent diabetics[J].Chin J Ophthalmol,2003,39(1):10-13.
[15] ALJAROUSHA M,BADARUDIN NE,CHE AZEMIN MZ.Comparison of dry eye parameters between diabetics and non-diabetics in district of Kuantan,Pahang[J].Malays J Med Sci,2016,23(3):72-77.
[16] FUERST N,LANGELIER N,MASSARO-GIORDANO M,PISTILLI M,STASI K,BURNS C,et al.Tear osmolarity and dry eye symptoms in diabetics[J].Clin Ophthalmol,2014,8:507-515.
[17] NAJAFI L,MALEK M,VALOJERDI AE,AGHILI R,KHAMSEH ME,FALLAH AE,et al.Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus[J].J Diabetes Compl,2013,27(5):459-462.
[18] NAJAFI L,MALEK M,VALOJERDI AE,KHAMSEH ME,AGHAEI H.Dry eye disease in type 2 diabetes mellitus;comparison of the tear osmolarity test with other common diagnostic tests:a diagnostic accuracy study using STARD standard[J].J Diabetes Metab Disord,2015,14:39.
[19] GRUS FH,SABUNCUO P,DICK HB,AUGUSTIN AJ,PFEIFFER N.Changes in the tear proteins of diabetic patients[J].BMC Ophthalmol,2002,2:4.
[20] LIU J,SHI B,HE S,YAO X,WILLCOX MD,ZHAO Z.Changes to tear cytokines of type 2 diabetic patients with or without retinopathy[J].Mol Vis,2010,16(10):2931-2938.
[21] PARK KS,KIM SS,KIM JC,KIM HC,IM YS,AHN CW,et al.Serum and tear levels of nerve growth factor in diabetic retinopathy patients[J].Am J Ophthalmol,2008,145(3):432-437.
[22] ZHAO Z,LIU J,SHI B,HE S,YAO X,WILLCOX MD.Advanced glycation end product(AGE)modified proteins in tears of diabetic patients[J].Mol Vis,2010,16(10):1576-1584.
[23] KIM HJ,KIM PK,YOO HS,KIM CW.Comparison of tear proteins between healthy and early diabetic retinopathy patients[J].Clin Biochem,2012,45(1-2):60-67.
[24] INOUE K,KATO S,OHARA C,NUMAGA J,AMANO S,OSHIKA T.Ocular and systemic factors relevant to diabetic keratoepitheliopathy[J].Cornea,2001,20(8):798-801.
[25] YAN G,YAN Z,RU YS,WANG XW,YANG JZ,LI CH,et al.Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy[J].Int J Ophthalmol,2015,8(2):358-364.
[26] MISRA SL,PATEL DV,MCGHEE CN,PRADHAN M,KILFOYLE D,BRAATVEDT GD,et al.Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus[J].J Diabetes Res,2014,2014:848659.
[27] 哈文静,邹文青,徐惠芳,顾青,李静.糖尿病患者的眼表面不规则指数[J].国际眼科杂志,2010,10(9):1704-1706.
HA WJ,ZOU WQ,XU HF,GU Q,LI J.Surface irregular index of the diabetics[J].Int Eye Sci,2010,10(9):1704-1706.
[28] PFLUGFELDER CS,TSENG SC,YOSHINO K,MONROY D,FELIX C,REIS BL.Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation[J].Ophthalmology,1997,104(2):223-235.
[29] BECKMAN KA.Characterization of dry eye disease in diabetic patients versus nondiabetic patients[J].Cornea,2014,33(8):851-854.
[30] SCHULTZ RO,Van HORN DL,PETERS MA,KLEWIN KM,SCHUTTEN WH.Diabetic keratopathy[J].Trans Am Ophthalmol Soc,1981,79:180-199.
[31] SATO E,MORI F,IGARASHI S,ABIKO T,TAKEDA M,ISHIKO S.Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy[J].Diabetes Care,2001,24(3):479-482.
[32] ZOU C,WANG S,HUANG F,ZHANG YA.Advanced glycation end products and uhrastrnctural changes in corneas of long-term streptozotocin-induced diabetic monkeys[J].Cornea,2012,31(12):1455-1459.
[33] REHANY U,ISHII Y,LAHAV M,RUMELT S.Uhrastructural changes in corneas of diabetic patients:an electron-microscopy study[J].Cornea,2000,19(4):534-538.
[34] AKIMOTO Y,SAWADA H,OHARA-IMAIZUMI M,NAGAMATSU S,KAWAKAMI H.Change in long-spacing collagen in Descemet’s membrane of diabetic Goto-Kakizaki rats and its suppression by antidiabetie agents[J].Exp Diabetes Res,2008,2008:818341.
[35] SUDHIR RR,RAMAN R,SHARMA T.Changes in the corneal endothelial cell density and morphology in patients with type 2 diabetes mellitus:a population-based study,Sankara Nethralaya Diabetic Retinopathy and Molecular Genetics Study[J].Cornea,2012,31(10):1119-1122.
[36] MODIS LJ,SZALAI E,KERTESZ K,KEMNY-BEKE A,KETTESY B,BERTA A.Evaluation of the corneal endothelium in patients with diabetes mellitus type I and II[J].Histol Histopathol,2010,25(12):1531-1537.
[37] Lee JS,Oum BS,Choi HY,Lee JE,Cho BM.Differences in corneal thickness and corneal endothelium related to duration in diabetes[J].Eye(Lond),2006,20(3):315-318.
[38] STORR-PAULSEN A,SINGH A,JEPPESEN H,NORREGAA-RD JC,THULESEN J.Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus[J].Acta Ophthalmol,2014,92(2):158-160.
[39] ZHIVOV A,WINTER K,HOVAKIMYAN M,PESCHEL S,HARDER V,SCHOBER HC,et al.Imaging and quantifieation of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy[J].PLoS One,2013,8:e52157.
[40] HE J,BAZAN HE.Mapping the nerve architecture of diabetic human coreas[J].Ophthalmology,2012,119(5):956-964.
[41] TAVAKOLI M,KALLINIKOS PA,EFRON N,BOULTON AJ,MALIK RA.Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes[J].Diabetes Care,2007,30(7):1895-1897.
[42] NISHIDA T,CHIKAMA T,SAWA M,MIYATA K,MATSUI T,SHIGETA K.Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders[J].Jpn J Ophthalmol,2012,56(1):20-25.
[43] ZHANG C,XI L,ZHAO S,WEI R,HUANG Y,YANG R,et al.Interleukin-1β and tumour necrosis factor-α levels in conjunctiva of diabetic patients with symptomatic moderate dry eye:case-control study[J].BMJ Open,2016,6(8):e010979.
[44] 杨宝珠,王家驰.II型糖尿病患者糖化血红蛋白质与视网膜、球结膜微循环改变的分析[J].中国慢性病预防与控制,1999,7(3):143-145.
YANG BZ,WANG JC.An analysis on the change of HbAlc and microcirculation of bulbar conjunctiva and retina in type 2 diabetic patients[J].Chin J Prev Contr Commun Diseases,1999,7(3):143-145.
[45] 高佳麟,陈锦礼.Ⅱ型糖尿患者球结膜微循环的临床观察[J].江苏医药,1995,21(9):593-594.
GAO JL,CHEN JL.A clinical observation in microcirculation of bulbar conjunctiva with type 2 diabetic patients[J].J Jiansu Med,1995,21(9):593-594.
[46] 张兴儒.结膜松弛与泪溢关系的临床研究[J].眼科,2001,10(4):224-226.
ZHANG XR.Epiphora and conjunctivochalasis-A clinical study[J].Ophthalmol Chin,2001,10(4):224-226.
[47] MDULO CM,JORGE AG,DIAS AC,BRAZ AM,BERTAZOLLI-FILHO R,JORDO AA Jr,et al.Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats[J].Endocrine,2009,36(1):161-168.
[48] ALVES M,CALEGARI VC,CUNHA DA,SAAD MJ,VELLOSO LA,ROCHA EM.Increased expression of advanced glycation end-products and their receptor,and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats[J].Diabetologia,2005,48(12):2675-2681.
[49] FINIS D,PISCHEL N,SEHRADER S,GEERLING G.Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meihomian gland dysfunction[J].Cornea,2013,32(12):1549-1553.
[50] EOM Y,CHOI KE,KANG SY,LEE HK,KIM HM,SONG JS.Comparison of meibomian gland loss and expressed meibum grade between the upper and lower eyelids in patients with obstructive meibomian gland dysfunction[J].Cornea,2014,33(5):448-452.
[51] MANAVIAT MR,RASHIDI M,AFKHAMI-ARDEKANI M,SHOJA MR.Prevalence of dry eye syndmme and diabetic retinopathy in type 2 diabetic patients[J].BMC Ophthalmol,2008,8:10.
[52] QUAILE MP,MELICH DH,JORDAN HL,NOLD JB,CHISM JP,POLLI JW,et al.Toxicity and toxicokinetics of metformin in rats[J].Toxicol Appl Pharmacol,2010,243(3):340-347.
[53] MYERBURG MM,KING JD Jr,OYSTER NM,FITCH AC,MAGILL A,BATY CJ,et al.AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells[J].Am J Respir Cell Mol Biol,2010,42(6):676-684.
[54] WILSON SM,MANSLEY MK,GETTY J,HUSBAND EM,INGLIS SK,HANSEN MK.Effects of peroxisome proliferator-aetivated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney[J].Br J Pharmacol,2010,159(3):678-688.
相似文献/References:
[1]丁文君 韦琦 梁皓 陈金卯 李霞 谭少健.糖尿病兔后发性白内障发生过程中晶状体上皮细胞增殖的变化[J].眼科新进展,2012,32(1):000.
[2]陈放 徐珊 吕伟红 程宏 张洪泉.糖尿病大鼠视网膜的氧化应激损伤及葛根素对其的干预作用[J].眼科新进展,2012,32(1):000.
[3]曾庆延 蒋华 牛晓光 吴尚操 喻长泰.单纯疱疹病毒性角膜炎患者双眼泪液功能改变[J].眼科新进展,2012,32(5):000.
[4]李晓艳 张卯年.褪黑素对糖尿病大鼠早期视网膜神经细胞凋亡的影响[J].眼科新进展,2012,32(6):000.
[5]楚静 陈忠平.普拉洛芬及羟苯磺酸钙在糖尿病患者白内障手术中的应用[J].眼科新进展,2013,33(8):000.
[6]张曙光 何跃 项杰 马林昆 李燕 袁援生.JNK2在早期糖尿病小鼠视网膜中的表达及作用[J].眼科新进展,2012,32(4):000.
[7]李艳 潘斌 李筱荣 袁佳琴 张杰.糖尿病大鼠视网膜PEDF表达与神经退行性改变[J].眼科新进展,2012,32(8):000.
[8]崔颖 郭海科 韩云飞 孟倩丽 张良 尹东明.2型糖尿病住院患者糖尿病视网膜病变患病率及危险因素分析[J].眼科新进展,2012,32(8):000.
[9]张谊 宋光辉 杨架林 张钰 肖强 潘璐 赵伟红 刘昊.糖尿病患者短期内血糖变化对黄斑区视网膜厚度的影响[J].眼科新进展,2012,32(10):000.
[10]赵恳.白内障超声乳化人工晶状体植入术对糖尿病患者角膜内皮细胞形态与功能的影响[J].眼科新进展,2013,33(4):000.